Company profile: Xymogen
1.1 - Company Overview
Company description
- Provider of dietary supplements and functional foods distributed via healthcare practitioners, featuring Omega MonoPure 1300 EC (cardiovascular, mental, glucose/insulin support), OptiMag Neuro (brain magnesium, cognitive, stress, sleep, mood), and ProbioMax DF (intestinal health, immune response, bowel regularity, lactose digestion), plus practitioner partnerships, private label design, and educational resources.
Products and services
- Practitioner Partnership: EHR-integrated service that supplies healthcare practitioners with access to supplements, protocol recommendations, and compliance support for practitioner-directed patient care
- Omega MonoPure® 1300 EC: Softgel-based supplement that delivers EPA and DHA to support cardiovascular health, mental functioning, and glucose and insulin metabolism for practitioner-dispensed clinical nutrition
- ProbioMax® DF: Capsule-based probiotic that supports intestinal health, immune response, bowel regularity, and lactose digestion, supplied through healthcare practitioners for targeted gastrointestinal care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xymogen
Oragenics
HQ: United States
Website
- Description: Provider of development-stage therapeutics and vaccines, including lantibiotics targeting antibiotic-resistant, healthcare-acquired infections; neurosteroids ONP-002 for moderate to severe concussion and ONP-001 for Niemann Pick Type-C disease; and NT-CoV-2, an intranasal COVID-19 vaccine candidate designed to enhance mucosal immunity and reduce needle use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oragenics company profile →
NutriLeads
HQ: The Netherlands
Website
- Description: Provider of plant-based precision prebiotic fibers and nutritional ingredients with demonstrated health effects. Partners with food industry companies to identify promising lead ingredients and develop sustainable, commercially viable production processes. Offers Benicaros, a precision prebiotic fiber from upcycled carrot pomace designed to enhance immune responses and improve gut microbiota composition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NutriLeads company profile →
Nature's Formulary
HQ: United States
Website
- Description: Provider of ayurvedic products, manufacturing and selling supplements including Arjuna (supports normal cardiac function and heart rate), Ashwagandha (combats stress, improves endurance, promotes better sleep), Boswellia (supports joint function), Guggul (supports healthy cholesterol and joints), Gymnema (reduces sugar cravings, supports sugar metabolism), Phyllanthus (supports liver health).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nature's Formulary company profile →
Biosearch Life
HQ: Spain
Website
- Description: Provider of a wide range of biotechnology products and services developed and manufactured through the innovation of natural ingredients, present across main international markets in the pharmaceutical, nutraceutical, and functional food sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosearch Life company profile →
Precon Health
HQ: United States
Website
- Description: Provider of wellness and fitness services as a healthcare center.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precon Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xymogen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xymogen
2.2 - Growth funds investing in similar companies to Xymogen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xymogen
4.2 - Public trading comparable groups for Xymogen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →